Leslie S. Kean, MD, PhD, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center explains the potential impact of abatacept, which is now FDA-approved to prevent acute graft-versus-host disease (GvHD) in...
Casey Wall always knew that she wanted to help others, so when she became a pediatric nurse practitioner, it just confirmed that this was her passion. Hear about her journey...
The Liver Tumor Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center takes a multidisciplinary, collaborative approach to treating our patients. Treatment requires thoughtful decision-making by a multidisciplinary team of...
When Emma was diagnosed with Fanconi anemia a few months after birth, her family was pleased to learn that one of the world’s leading team of experts in the disease...
"This is a celebration of hope, dedication, and gratitude." Dr. Kevin Churchwell, President and CEO of Boston Children's Hospital, thanks all of those who made Boston Children's the #1 pediatric...
Retinoblastoma is a rare form of childhood eye cancer. How can genetics influence which kids are at risk? This animated video explains hereditary and non-hereditary retinoblastoma in simple terms.
Oona was diagnosed with thyroid cancer when she was a child. Learn how she found the right treatment and care at Boston Children’s Thyroid Center.
